TURUN YLIOPISTO Patent applications |
Patent application number | Title | Published |
20160135717 | METHOD AND APPARATUS FOR DETERMINING INFORMATION INDICATIVE OF CARDIAC MALFUNCTIONS - An apparatus for determining information indicative of cardiac malfunctions includes a processing device ( | 05-19-2016 |
20160049295 | METHOD FOR TREATING A SUBSTRATE AND A SUBSTRATE - A method for treating a compound semiconductor substrate, in which method in vacuum conditions a surface of an In-containing III-As, III-Sb or III-P substrate is cleaned from amorphous native oxides and after that the cleaned substrate is heated to a temperature of about 250-550° C. and oxidized by introducing oxygen gas onto the surface of the substrate. The invention relates also to a compound semiconductor substrate, and the use of the substrate in a structure of a transistor such as MOSFET. | 02-18-2016 |
20150209369 | COMBINATION THERAPY III - The invention is based on a finding that silencing HDAC4gene sensitizes cancer cells for apoptosis-inducing activity of certain small molecule chemotherapeutic agents. Thus, the invention is directed to a respective combination therapy, sensitization method and pharmaceutical compositions. | 07-30-2015 |
20150204877 | METHOD OF SELECTING INDIVIDUALIZED BRAIN CANCER THERAPY - The present invention relates to a method of selecting individualized brain cancer therapy on the basis of the patient's PME-1 expression level in the diseased tissue. | 07-23-2015 |
20150133806 | METHOD AND APPARATUS FOR DETERMINING INFORMATION INDICATIVE OF CARDIAC MALFUNCTIONS AND ABNORMALITIES - An apparatus for determining information indicative of cardiac malfunctions and abnormalities includes a processing device ( | 05-14-2015 |
20150065894 | METHOD AND APPARATUS FOR DETERMINING INFORMATION INDICATIVE OF CARDIAC MALFUNCTIONS AND ABNORMALITIES - An apparatus for determining information indicative of cardiac malfunctions and abnormalities includes a processing device ( | 03-05-2015 |
20140199415 | PHARMACEUTICAL COMBINATION COMPRISING A CIP2A SILENCING AGENT FOR USE IN THE TREATMENT OF A HYPERPROLIFERATIVE DISORDER, PREFERABLY ONE WITH IMPAIRED P53 FUNCTION - The invention is based on a finding that silencing CIP2A (KI-AA1524) gene sensitizes cancer cells for apoptosis-inducing activity of certain small molecule chemotherapeutic agents. Thus, the invention is directed to a respective combination therapy, sensitization method and pharmaceutical compositions. The invention further relates to a method of selecting cancer therapy for a subject on the basis of CIP2A and p53 expression and/or protein activity in a sample obtained from said subject. | 07-17-2014 |
20140135377 | COMBINATION THERAPY - The invention is based on a finding that silencing PME-1 gene sensitizes cancer cells for apoptosis-inducing activity of certain small molecule chemotherapeutic agents. Thus, the invention is directed to a respective combination therapy, sensitization method and pharmaceutical compositions. | 05-15-2014 |
20140105932 | MULTIVALENT [BETA] - 1 - 2 - LINKED MANNOSE OLIGOSACCHARIDES AS IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF - This invention relates to synthetic oligo- or multivalent beta-1-2-linked mannooligosaccharide compounds and to their use for modulating T helper (Th) and T regulatory (Treg) cell-mediated immune responses. | 04-17-2014 |
20130214331 | METHOD FOR TREATING A SUBSTRATE AND A SUBSTRATE - A method for treating a compound semiconductor substrate, in which method in vacuum conditions a surface of an In-containing III-As, III-Sb or III-P substrate is cleaned from amorphous native oxides and after that the cleaned substrate is heated to a temperature of about 250-550° C. and oxidized by introducing oxygen gas onto the surface of the substrate. The invention relates also to a compound semiconductor substrate, and the use of the substrate in a structure of a transistor such as MOSFET. | 08-22-2013 |
20130197063 | USE OF A GROWTH-STIMULATING PROTEIN - This invention relates to the inhibition of a newly discovered growth-stimulating protein in an individual. Further, the invention relates to a method for preventing or treating a cancer, or preventing or treating cancer growth, invasion or metastasis, or preventing or treating other hyperproliferative diseases in an individual, by down regulating the expression of said growth-stimulating protein or by inactivating said protein. Still further, the invention concerns a method for diagnosing cancer or other hyperproliferative diseases in an individual based on said growth-stimulating protein. | 08-01-2013 |
20130045507 | Mutagenesis Method - The present invention provides a mutagenesis method wherein a nucleic acid molecule is mutagenized with at least one mutagenesis primer in a primer extension reaction and subsequently amplified by rolling circle amplification (RCA). The method involves steps leading to selective amplification of only the mutated strand by a strand-displacing DNA polymerase. Multiple copies of the mutated plasmids are generated during multiple-primed RCA and the resulting DNA is transformed for use. The method is suitable for mutating both single-stranded and double-stranded DNA. The present invention also provides a kit for use in the mutagenesis method. | 02-21-2013 |
20100132423 | METHOD FOR IMPROVING VERMICULITE'S INTAKE OF AMMONIUM IONS, ABSORPTION MATERIAL, ITS USES AND METHOD OF REMOVING AMMONIUM FROM ENVIRONMENT - The invention relates to a method for improving vermiculite's intake of ammonium, in which method heating of the crude vermiculite is conducted to a temperature where vermiculite's third dehydration step takes place, the temperature being lower than the temperature where vermiculite's fourth dehydration/dehydroxylation step takes place. The invention relates also to use of the obtained vermiculite and to an absorption material, comprising vermiculite material and additives, where at least 50% of the vermiculite material comprises vermiculite, which has undergone the third dehydration step but not the fourth dehydration/dehydroxylation step. The invention relates also to use of thermally treated and ammonium doped vermiculite as fertilizer/soil conditioner. | 06-03-2010 |